Article

Online meds database now downloadable to PDA

Eye-care professionals (ECPs) can now access Transitions Optical Inc.'s Ocular Side Effects Database wherever they go, without even logging online. The database is now available for download to a Personal Digital Assistant (PDA).

Pinellas Park, FL-Eye-care professionals (ECPs) can now access Transitions Optical Inc.'s Ocular Side Effects Database wherever they go, without even logging online. The database is now available for download to a Personal Digital Assistant (PDA).

Downloadable from http://www.transitions.com/medications, the Ocular Side Effects Database provides access to information on medications that may pose a threat to healthy sight. The database enables ECPs to search quickly for drugs by brand name to determine which medications may affect vision. It also provides details on how the quality and quantity of vision can be affected by each drug.

"As the number of Americans taking prescription or over-the-counter medications continues to rise, it becomes increasingly important for ECPs to educate their patients on the possible ocular side effects-particularly since nearly 25% of patients don't tell their ECPs what medications they're taking," said Carole Bratteig, manager, education and training, Transitions.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.